The Effect of Irritable Bowel Syndrome on Health-Related Quality of Life and Health Care Expenditures

Gastroenterology Clinics of North America

Volumn 40, Issue 1, 2011, Pages 11-19

  Agarwal, Nikhil ^a   Spiegel, Brennan M R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Health care expenditures; Health related quality of life; Irritable bowel syndrome

Indexed keywords

ABSENTEEISM; ANAMNESIS; ANXIETY DISORDER; ARTICLE; COLONOSCOPY; DEPRESSION; DISEASE ASSOCIATION; EMOTIONAL STRESS; GASTROINTESTINAL SYMPTOM; HEALTH CARE COST; HUMAN; IRRITABLE COLON; MEDICAL DECISION MAKING; MOOD DISORDER; PREVALENCE; PRODUCTIVITY; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; SEXUAL DYSFUNCTION; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; SOMATIZATION; SUICIDAL BEHAVIOR; SYMPTOM;

EID: 79951569700     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gtc.2010.12.013     Document Type: Review

References (41)

1. Longstreth G.F., Thompson W.G., Chey W.D., et al. Functional bowel disorders. Gastroenterology 2006, 130:1480-1491.
2. El-Serag H.B., Olden K., Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002, 16:1171-1185.
3. Gralnek I.M., Hays R.D., Kilbourne A., et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000, 119:654-660.
4. Saito Y.A., Schoenfeld P., Locke G.R. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002, 97:1910-1915.
5. Systematic review on the management of irritable bowel syndrome in the European Union. Eur J Gastroenterol Hepatol 2007, 19(Suppl 1):S11-S37.
6. Saito Y.A., Talley N.J., Melton L.J., et al. The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates. Neurogastroenterol Motil 2003, 15:687-694.
7. Andrews E.B., Eaton S.C., Hollis K.A., et al. Prevalence and demographics of irritable bowel syndrome: results from a large Web-based survey. Aliment Pharmacol Ther 2005, 22:935-942.
8. Hungin A.P., Chang L., Locke G.R., et al. Irritable bowel syndrome in the United States: prevalence, symptom patterns, and impact. Aliment Pharmacol Ther 2005, 21:1365-1375.
9. Minocha A., Johnson W.D., Abell T.L., et al. Prevalence, sociodemography, and quality of life of older versus younger patients with irritable bowel syndrome: a population-based study. Dig Dis Sci 2006, 51:446-453.
10. Brandt L.J., Chey W.D., Foxx-Orenstein A.E., et al. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009, 104(Suppl 1):S1-S35.
11. Dunphy R.C., Bridgewater L., Price D.D., et al. Visceral and cutaneous hypersensitivity in Persian Gulf War veterans with chronic gastrointestinal symptoms. Pain 2003, 102:79-85.
12. Gray G.C., Reed R.J., Kaiser K.S., et al. Self-reported symptoms and medical conditions among 11,868 Gulf War-era veterans: the Seabee Health Study. Am J Epidemiol 2002, 155:1033-1044.
13. Hunt S.C., Richardson R.D. Chronic multisystem illness among Gulf War veterans. JAMA 1999, 282:327-328. [author reply: 328-9].
14. Spiegel B., Harris L., Lucak S., et al. Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort. Am J Gastroenterol 2009, 104:1984-1991.
15. Miller V., Hopkins L., Whorwell P.J. Suicidal ideation in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2004, 2:1064-1068.
16. Spiegel B., Schoenfeld P., Naliboff B. Systematic review: the prevalence of suicidal behaviour in patients with chronic abdominal pain and irritable bowel syndrome. Aliment Pharmacol Ther 2007, 26:183-193.
17. Hahn B.A., Kirchdoerfer L.J., Fullerton S., et al. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization, and quality of life. Aliment Pharmacol Ther 1997, 11:553-559.
18. Naliboff B.D., Balice G., Mayer E.A. Psychosocial moderators of quality of life in irritable bowel syndrome. Eur J Surg Suppl 1998, 583:57-59.
19. Spiegel B.M., Gralnek I.M., Bolus R., et al. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome. Arch Intern Med 2004, 164:1773-1780.
20. van der Veek P.P., van Rood Y.R., Masclee A.A. Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome. Aliment Pharmacol Ther 2007, 26:943-952.
21. Lembo A., Ameen V.Z., Drossman D.A. Irritable bowel syndrome: toward an understanding of severity. Clin Gastroenterol Hepatol 2005, 3:717-725.
22. Shaw G., Srivastava E.D., Sadlier M., et al. Stress management for irritable bowel syndrome: a controlled trial. Digestion 1991, 50:36-42.
23. Spiegel B.M.R., Naliboff B., Mayer E., et al. The effectiveness of a model physician-patient relationship versus usual care in irritable bowel syndrome: a randomized controlled trial. Gastroenterology 2006, 130:A773.
24. Patrick D.L., Drossman D.A. Comparison of IBS-36 and IBS-QOL instruments. Am J Gastroenterol 2002, 97:3204. [author reply: 3204-5].
25. Patrick D.L., Drossman D.A., Frederick I.O., et al. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998, 43:400-411.
26. Drossman D.A., Patrick D.L., Whitehead W.E., et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000, 95:999-1007.
27. Spiegel B.M.R., Naliboff, Mayer E., et al. Development and initial validation of a concise point-of-care IBS severity index: the 4-item BEST questionnaire. Gastroenterology 2006, 130:S1040.
28. Everhart J.E., Ruhl C.E. Burden of digestive diseases in the United States part 2: lower gastrointestinal diseases. Gastroenterology 2009, 136(3):741-754.
29. Talley N.J., Gabriel S.E., Harmsen W.S., et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995, 109:1736-1741.
30. Longstreth G.F., Wilson A., Knight K., et al. Irritable bowel syndrome, health care use, and costs: a US managed care perspective. Am J Gastroenterol 2003, 98:600-607.
31. Longstreth G.F. Avoiding unnecessary surgery in irritable bowel syndrome. Gut 2007, 56:608-610.
32. Longstreth G.F., Yao J.F. Irritable bowel syndrome and surgery: a multivariable analysis. Gastroenterology 2004, 126:1665-1673.
33. Lieberman D.A., Holub J., Eisen G., et al. Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc 2005, 62:875-883.
34. Spiegel B.M., Gralnek I.M., Bolus R., et al. Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome?. Gastrointest Endosc 2005, 62:892-899.
35. Chey W.D., Nojkov B., Rubenstein J.H., et al. The yield of colonoscopy in patients with nonconstipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol 2010, 105:859-865.
36. Whitehead W.E., Palsson O., Jones K.R. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology 2002, 122:1140-1156.
37. Miller A.R., North C.S., Clouse R.E., et al. The association of irritable bowel syndrome and somatization disorder. Ann Clin Psychiatry 2001, 13:25-30.
38. Spiegel B.M., Kanwal F., Naliboff B., et al. The impact of somatization on the use of gastrointestinal health care resources in patients with irritable bowel syndrome. Am J Gastroenterol 2005, 100:2262-2273.
39. Pare P., Gray J., Lam S., et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Clin Ther 2006, 28:1726-1735. [discussion: 1710-1].
40. Dean B.B., Aguilar D., Barghout V., et al. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Manag Care 2005, 11:S17-S26.
41. Spiegel B.M.R., Harris L., Lucak S., et al. Predictors of work productivity in irritable bowel syndrome (IBS): results from the PROOF cohort. Gastroenterology 2008, 134:AB157.